PediatRx Inc. (Seller)Apricus Biosciences (Buyer)
Apricus acquiring PediatRx for about $4 million in stock and the assumption of $675,000 of PediatRx's debt
Bi-Coastal Pharmaceutical (Licensor)PediatRx Inc. (Licensee)
Bi-Coastal granted PediatRx co-promotion rights to Aquoral oxidized glycerol triesters in the U.S.
Set Email Alert